Alto Neuroscience, Inc.ANRONYSE
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-19.80%
↓ 439% below average
Average (11q)
5.84%
Historical baseline
Range
High:32.48%
Low:-19.80%
Volatility
895.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -19.80% |
| Q2 2025 | 31.58% |
| Q1 2025 | -7.65% |
| Q4 2024 | -17.30% |
| Q3 2024 | -0.94% |
| Q2 2024 | 32.48% |
| Q1 2024 | 3.20% |
| Q4 2023 | 21.04% |
| Q3 2023 | 12.66% |
| Q2 2023 | 26.08% |
| Q1 2023 | -11.31% |
| Q4 2022 | 0.00% |